Nice | Familial breast cancer

18th July 2013 by Louise Hudman

This familial breast cancer guideline doesn’t change anything for us. Our role is to risk assess women and refer on to the genetics services if they may be at high risk. NICE do say that this shouldn’t be screening, but a response to a concerned woman, or if there seems to be a significant history on doing a pill or HRT check.

Also of interest is that ‘TP53’ is now tested for, alongside BRCA1 and 2

How to do a familial breast cancer risk assessment

This hasn’t changed from the last guideline. There was a handy flowchart in the last guideline, which I keep printed out to use.

Combined oral contraceptive (COC) use

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"...the NASGP LocumDeck service makes my running things as a self employed GP almost effortless - I don't think I would want to work without it. Invoicing is streamlined and the website is very user-friendly. After a sometimes busy week at work the last thing you want is to spend hours on business admin - LocumDeck is a real timesaver."

Dr James O’Mahony

See the full list of features within our NASGP membership plans

Membership